Established in 2006, the IFPA Conference (also known as the World Psoriasis & Psoriatic Arthritis Conference) provides a unique, cross-specialty platform. Medical and health professionals present frontline clinical research in dermatology, rheumatology and beyond. Delegates can explore psoriatic disease from different perspectives by networking with patients and industry representatives in attendance. The IFPA conference calls for breakthroughs in research that will improve the understanding of all aspects of psoriatic disease.
The next conference will be held 20–22 May, 2027 in Stockholm, Sweden.
The theme of this Conference is: Bridging science, innovation and patient care
Principles of the IFPA Conference
- Increase global recognition of the seriousness of the diseases and to develop a broader international perspective of psoriatic disease
- Encourage collaboration on developing future research and advocacy initiatives.
- Increase awareness by medical professionals and industry of the role of IFPA and its members in assisting the medical advancement in psoriatic disease.
Developing a scientific program for all
- Patients in IFPA’s network propose themes in a global survey
- The Scientific Executive Committee develops the Conference program with patient priorities in focus
- The Scientific Advisory Board and Program Committee reviews the program for quality assurance
- The IFPA Conference aligns scientific progress with patient priorities, unleashing breakthroughs for experts of all backgrounds
